Log in to save to my catalogue

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3428079

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

About this item

Full title

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2012-09, Vol.122 (9), p.3127-3144

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

The chemokine receptor CXCR2 is a key mediator of neutrophil migration that also plays a role in tumor development. However, CXCR2 influences tumors through multiple mechanisms and might promote or inhibit tumor development depending on context. Here, we used several mouse models of spontaneous and inflammation-driven neoplasia to define indispensa...

Alternative Titles

Full title

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3428079

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3428079

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI61067

How to access this item